Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy.
Das A, Brugge W, Mishra G, Smith DM, Sachdev M, Ellsworth E. Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy. Endosc Int Open. 2015 Oct; 3(5):E479-86.